Intrathecal DepoCyte and Lineage-targeted Minimal Residual Disease-oriented Therapy of Acute Lymphoblastic Leukemia
Clinical trial NCT00795756 · COMPLETED
Trial details
- NCT number
- NCT00795756
- Sponsor
- Northern Italy Leukemia Group
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2008-01-01
- Primary completion
- 2013-10-01
- Enrollment
- 145
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.